These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
606 related articles for article (PubMed ID: 2465135)
1. Role of adenosine 3',5'-monophosphate and the Ri-receptor Gi-coupled adenylate cyclase inhibitory pathway in the mechanism whereby adrenalectomy increases the adenosine antilipolytic effect in rat fat cells. de Mazancourt P; Lacasa D; Giot J; Giudicelli Y Endocrinology; 1989 Mar; 124(3):1131-9. PubMed ID: 2465135 [TBL] [Abstract][Full Text] [Related]
2. Cellular tolerance to adenosine receptor-mediated inhibition of lipolysis: altered adenosine 3',5'-monophosphate metabolism and protein kinase activation. Hoffman BB; Prokocimer P; Thomas JM; Vagelos R; Chang H; Reaven GM Endocrinology; 1989 May; 124(5):2434-42. PubMed ID: 2539980 [TBL] [Abstract][Full Text] [Related]
3. Winner of the 1988 NAASO Young Investigator Award. Regulation of fat cell adenylate cyclase in young Zucker (fa/fa) rats: alterations in GTP sensitivity of adenosine A1 mediated inhibition. Vannucci SJ; Klim CM; LaNoue KF; Martin LF Int J Obes; 1990; 14 Suppl 3():125-34. PubMed ID: 1964933 [TBL] [Abstract][Full Text] [Related]
4. Insulin stimulation of cyclic AMP phosphodiesterase is independent from the G-protein pathways involved in adenylate cyclase regulation. Weber HW; Chung FZ; Day K; Appleman MM J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):345-54. PubMed ID: 3040818 [TBL] [Abstract][Full Text] [Related]
5. Effect of N6-(L-2-phenylisopropyl)adenosine and insulin on cAMP metabolism in 3T3-L1 adipocytes. Elks ML; Jackson M; Manganiello VC; Vaughan M Am J Physiol; 1987 Mar; 252(3 Pt 1):C342-8. PubMed ID: 3030132 [TBL] [Abstract][Full Text] [Related]
6. Adenosine inhibition of the hormonal response in the Sertoli cell is reversed by pertussis toxin. Monaco L; DeManno DA; Martin MW; Conti M Endocrinology; 1988 Jun; 122(6):2692-8. PubMed ID: 2836171 [TBL] [Abstract][Full Text] [Related]
7. A1-adenosine receptor-mediated inhibition of adipocyte adenylate cyclase and lipolysis in Zucker rats. Vannucci SJ; Klim CM; Martin LF; LaNoue KF Am J Physiol; 1989 Dec; 257(6 Pt 1):E871-8. PubMed ID: 2558574 [TBL] [Abstract][Full Text] [Related]
8. The role of insulin-sensitive phosphodiesterase in insulin action. Makino H; Suzuki T; Kajinuma H; Yamazaki M; Ito H; Yoshida S Adv Second Messenger Phosphoprotein Res; 1992; 25():185-99. PubMed ID: 1372810 [TBL] [Abstract][Full Text] [Related]
9. Desensitization of adenosine receptor-mediated inhibition of lipolysis. The mechanism involves the development of enhanced cyclic adenosine monophosphate accumulation in tolerant adipocytes. Hoffman BB; Chang H; Dall'Aglio E; Reaven GM J Clin Invest; 1986 Jul; 78(1):185-90. PubMed ID: 3013937 [TBL] [Abstract][Full Text] [Related]
10. Regulation of the GTP-binding protein-based antilipolytic system of sheep adipocytes by growth hormone. Doris RA; Kilgour E; Houslay MD; Vernon RG J Endocrinol; 1998 Sep; 158(3):295-303. PubMed ID: 9846158 [TBL] [Abstract][Full Text] [Related]
11. N6-phenylisopropyladenosine stimulates in normal and inhibits in adrenalectomized rats the low KM cyclic AMP phosphodiesterase in the brain. de Mazancourt P; Giudicelli Y Brain Res; 1984 May; 300(2):211-7. PubMed ID: 6329432 [TBL] [Abstract][Full Text] [Related]
12. The new cardiotonic agent sulmazole is an A1 adenosine receptor antagonist and functionally blocks the inhibitory regulator, Gi. Parsons WJ; Ramkumar V; Stiles GL Mol Pharmacol; 1988 Apr; 33(4):441-8. PubMed ID: 3128727 [TBL] [Abstract][Full Text] [Related]
13. Adenosine receptor-mediated effects by nonmetabolizable adenosine analogs in preovulatory rat granulosa cells: a putative local regulatory role of adenosine in the ovary. Billig H; Thelander H; Rosberg S Endocrinology; 1988 Jan; 122(1):52-61. PubMed ID: 2826114 [TBL] [Abstract][Full Text] [Related]
14. Effects of hypothyroidism on brown adipose tissue adenylyl cyclase activity. Carvalho SD; Bianco AC; Silva JE Endocrinology; 1996 Dec; 137(12):5519-29. PubMed ID: 8940379 [TBL] [Abstract][Full Text] [Related]
15. Diabetes abolishes the GTP-dependent, but not the receptor-dependent inhibitory function of the inhibitory guanine-nucleotide-binding regulatory protein (Gi) on adipocyte adenylate cyclase activity. Strassheim D; Milligan G; Houslay MD Biochem J; 1990 Mar; 266(2):521-6. PubMed ID: 2156498 [TBL] [Abstract][Full Text] [Related]
16. The new positive inotrope sulmazole inhibits the function of guanine nucleotide regulatory proteins by affecting GTP turnover. Ramkumar V; Stiles GL Mol Pharmacol; 1988 Dec; 34(6):761-8. PubMed ID: 2849044 [TBL] [Abstract][Full Text] [Related]
17. The inhibitory GTP-binding protein (Gi) regulates the agonistic property of beta-adrenergic ligands in isolated rat adipocytes. Evidence for a priming effect of cyclic AMP. Wesslau C; Smith U Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):41-6. PubMed ID: 1280115 [TBL] [Abstract][Full Text] [Related]
18. Coupling of adenylate cyclase to lipolysis in permeabilized adipocytes: direct evidence that an antilipolytic effect of insulin is independent of adenylate cyclase. Mooney RA; Swicegood CL; Marx RB Endocrinology; 1986 Nov; 119(5):2240-8. PubMed ID: 3095104 [TBL] [Abstract][Full Text] [Related]
19. A1-adenosine receptor inhibition of adenylate cyclase in failing and nonfailing human ventricular myocardium. Hershberger RE; Feldman AM; Bristow MR Circulation; 1991 Apr; 83(4):1343-51. PubMed ID: 1901530 [TBL] [Abstract][Full Text] [Related]
20. Somatostatin inhibits corticotropin-releasing factor-stimulated adrenocorticotropin release, adenylate cyclase, and activation of adenosine 3',5'-monophosphate-dependent protein kinase isoenzymes in AtT20 cells. Litvin Y; Leiser M; Fleischer N; Erlichman J Endocrinology; 1986 Aug; 119(2):737-45. PubMed ID: 2426087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]